CRISPR makes prostate cancer vulnerable to immunotherapy
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"CRISPR makes prostate cancer vulnerable to immunotherapy" is generating significant coverage in the Health category, with 6 articles from 6 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Eastleigh Voice, Technology Networks, Medical Daily and Ynetnews. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 107d ago.
Quick answers
Why is "CRISPR makes prostate cancer vulnerable to immunotherapy" trending?
Because 6 independent news sources published 6 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (6)
- Breakthrough RNA therapy could boost immunotherapy for prostate cancer, study finds The Eastleigh Voice · 111d ago
- Reprogramming Immune-Cold Prostate Tumors Improves Therapeutic Response Technology Networks · 111d ago
- Scientists Found How Prostate Tumors Vanish from the Immune System's Radar and How to Make Them Visible Again Medical Daily · 111d ago
- Gene editing may help the immune system find prostate cancer Ynetnews · 111d ago
- New Tool Supercharges Immunotherapy Against Prostate Cancer SciTechDaily · 111d ago
- CRISPR makes prostate cancer vulnerable to immunotherapy ScienceDaily · 111d ago
Topics
Related trends
Anthropic CEO says AI could cure most major diseases within next decade
Anthropic reports its AI model Claude discovered a novel CRISPR-like enzyme system.
A transplanted pig kidney buys time for a human one to become available
A genetically modified pig kidney functioned in a human body for a record nine months as a bridge to a human transplant.
Gene-edited beagles may offer a future option for people with dog allergies
Kindred Companion Sciences has used CRISPR gene-editing to create hypoallergenic beagles by removing a major allergy-causing protein.
Scientists edit human DNA inside the body for the first time
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Gene therapy that led to boy’s death had limited efficacy
Recent coverage examines a fatal gene-editing trial in China that showed limited efficacy alongside severe safety concerns.
A first for CRISPR: powerful prime editing alters DNA directly in the human body
Scientists have conducted the first-ever test of prime editing to alter DNA directly inside the human body, potentially offering a cure for genetic diseases.